1-13 of 13
Olga Militano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731

Rachel E. Rau, Sumit Gupta, John A. Kairalla, Karen R Rabin, Anne Angiolillo, Cindy Wang, Andrew J. Carroll, Susan Conway, Meenakshi Devidas, Lia Gore, Ilan R. Kirsch, Holly R. Kubaney, Amanda M Li, Jennifer L. McNeer, Olga Militano, Yvonne Moyer, Maureen M. O'Brien, Maki Okada, Shalini C. Reshmi, Mary Shago, Elizabeth R. Wagner, Naomi J. Winick, Brent L. Wood, Faraz Zaman, Gerhard Zugmaier, Sue Zupanec, Stephen P. Hunger, David T. Teachey, Elizabeth A. Raetz, Mignon L. Loh
Journal: Blood
Blood (2024) 144 (Supplement 1): 1.
https://doi.org/10.1182/blood-2024-207450
Published: 2024
Journal Articles

A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group

Jessica A. Pollard, Todd A. Alonzo, Robert Gerbing, Matthew A. Kutny, Betsy Hirsch, Gordana Raca, Kasey Leger, Jennifer J. Wilkes, Aman Wadhwa, Zachary Graff, Reena Pabari, Samir Kahwash, Karen M Chisholm, Joseph Chewning, John T. Horan, Richard Aplenc, Katherine Tarlock, Sarah Menig, Olga Militano, Bonnie Ky, Chad A. Hudson, Lisa Eidenschink Brodersen, Michael R. Loken, Soheil Meshinchi, Anders Kolb, Todd M Cooper
Journal: Blood
Blood (2024) 144 (Supplement 1): 967.
https://doi.org/10.1182/blood-2024-205666
Published: 2024
Journal Articles

PEPN2312: A Pediatric Early Phase Clinical Trials Network (PEP-CTN) Phase 1 Trial of Imetelstat with Fludarabine/Cytarabine in Pediatric Patients with Relapsed/Refractory AML, MDS, or JMML

Alexandra McLean Stevens, Maureen M. O'Brien, Xiaowei Liu, Charles G Minard, Olga Militano, Joel M Reid, Shyamala Navada, Todd M Cooper, Sarah K. Tasian, Elizabeth Fox, Brenda J. Weigel
Journal: Blood
Blood (2024) 144 (Supplement 1): 4265.4.
https://doi.org/10.1182/blood-2024-207907
Published: 2024
Journal Articles

Safety and Activity of Flotetuzumab in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results from the COG PEPN1812 Phase 1 Trial

Adam J. Lamble, Xiaowei Liu, Charles Minard, Olga Militano, Melanie Brooke Bernhardt, Todd M. Cooper, Edward A. Kolb, Erin H. Breese, Elizabeth Fox, Sarah K Tasian, Brenda J. Weigel
Journal: Blood
Blood (2022) 140 (Supplement 1): 6209–6210.
https://doi.org/10.1182/blood-2022-158029
Published: 2022
Journal Articles

Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731

Amanda M. Li, Karen R Rabin, John Kairalla, Cindy Wang, Meenakshi Devidas, Olga Militano, Maki Okada, Johann K Hitzler, Anne L Angiolillo, Elizabeth A. Raetz, Mignon L. Loh, Sumit Gupta, Rachel E. Rau
Journal: Blood
Blood (2021) 138 (Supplement 1): 2304.
https://doi.org/10.1182/blood-2021-148967
Published: 2021
Journal Articles

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732

Jennifer L. McNeer, Maureen M. O'Brien, Susan R. Rheingold, Meenakshi Devidas, Zhiguo Chen, Deepa Bhojwani, Anurag K. Agrawal, Brent Wood, Eugene Suh, Sarah Alexander, Tamara P. Miller, Olga Militano, Elizabeth A. Raetz, Mignon L. Loh
Journal: Blood
Blood (2021) 138 (Supplement 1): 3398.
https://doi.org/10.1182/blood-2021-149478
Published: 2021
Journal Articles

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621

Maureen M O'Brien, MD, Lingyun Ji, PhD, Nirali N. Shah, MD, Susan R. Rheingold, MD, Deepa Bhojwani, MD, Joanna S. Yi, MD, Constance M. Yuan, MD PhD, Andrew C Harris, MD, Patrick A. Brown, MD, Michael J. Borowitz, MD PhD, Olga Militano, PharmD, Meenakshi Devidas, PhD, Elizabeth A. Raetz, MD, Lia Gore, MD, Mignon L. Loh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 741.
https://doi.org/10.1182/blood-2019-128977
Published: 2019
Journal Articles

Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD)

Mitchell Cairo, MD, Susan K Parsons, MD MRP, Suzanne Braniecki, PhD, Julie-An Talano, MD, Theodore B Moore, MD, Qiuhu Shi, PhD, Carolyn A. Keever-Taylor, DPhil, Rona Singer Weinberg, PhD, Brenda J. Grossman, MD, Allen J Dozor, MD, Deborah Friedman, MD, Robert C McKinstry, MD PhD, James Verbsky, Chitti R Moorthy, MD, Ruth Ann Weidner, MBA, MRP, Angie Mae Rodday, PhD, Janet Ayello, MS, MT(ASCP), Mildred Semidei-Pomales, MS, Allyson M. Flower, MD, Yaya Chu, PhD, Erin Morris, RN, BSN, Harshini Mahanti, BS, MSCR, Sandra Fabricatore, RN, PNP, MSN, Olga Militano, PharmD, Liana Klejmont, Pharm D, Carmella van de Ven, MA, Lee Ann Baxter-Lowe, PhD, Elliott Vichinsky, MD, Mark C. Walters, MD, Shalini Shenoy, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 162.
https://doi.org/10.1182/blood-2018-162
Published: 2018
Journal Articles

A Pilot Trial of Unmatched Human Placenta-Derived Stem Cells (HPDSCs) in Conjunction with Unrelated Cord Blood Transplantation (UCBT) in Children and Young Adults with Malignant and Non-Malignant Disease (IND 14949)

Allyson M. Flower, MD, Michelle Nash, MD, Suzan Minzer, RN, MSN, FNP, Lauren Harrison, RN, MSN, Michael A Pulsipher, MD, Qiuhu Shi, PhD, Debra Abrams, MGC, CGC, MLIS, Roger H. Giller, MD, Erin Morris, RN, Olga Militano, PharmD, Janet Ayello, MS, Mildred Semidei-Pomales, Sandra Fabricatore, MSN, RN, PNP, Xiaokui Zhang, Jodi Gurney, Carmella van de Ven, MA, Cori M. Abikoff, MD, Jessica C. Hochberg, MD, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2016) 128 (22): 4671.
https://doi.org/10.1182/blood.V128.22.4671.4671
Published: 2016
Journal Articles

Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359)

Cori M. Abikoff, MD, Julie-An Talano, MD, Carolyn A. Keever-Taylor, PhD, Mark C. Walters, MD, Shalini Shenoy, MD, Theodore Moore, MD, Susan K. Parsons, MD MRP, Allen J Dozor, MD, Deborah Friedman, MD, Ramanamoorthy Chitti, MD, Qiuhu Shi, PhD, Brenda J. Grossman, MD MPH, Rona Singer Weinberg, PhD, Erin Morris, RN, Phyllis Brand, RN, MPH, Sandra Foley, CPNP, Olga Militano, PharmD, Janet Ayello, MS, MT(ASCP), Mildred Semidei-Pomales, MS, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2014) 124 (21): 2582.
https://doi.org/10.1182/blood.V124.21.2582.2582
Published: 2014
Journal Articles

Pharmacokinetics (PK) of Mycophenolate Mofetil (MMF) in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Are Associated with Significantly Higher Clearance.

Olga Militano, Kate Roache, Leslie M. Shaw, Michael Figurski, Prakash Satwani, Janet Ayello, Karen Wolownik, Sandra Foley, Ria Hawkes, Gustavo Del Toro, M. Brigid Bradley, Diane George, James Garvin, Monica Bhatia, Liz Roman, Mitchell S. Cairo
Journal: Blood
Blood (2005) 106 (11): 1823.
https://doi.org/10.1182/blood.V106.11.1823.1823
Published: 2005
Journal Articles

Preliminary Results of Reduced Intensity Allogeneic Stem Cell Transplantation (RI ALLOSCT) followed by a Dose Escalation of Targeted Consolidative Immunotherapy with Gemtuzumab Ozogamicin (GO) in Pediatric Recipients with CD33+ AML.

Elizabeth Roman, MD, Lauren Harrison, RN, Erin Cooney, CPNP, Olga Militano, Pharm, Karen Wolownik, MSN, CPNP, Ria Hawks, MSN, CPNP, Mary Brigid Bradley, MD, Gustavo Del Toro, MD, Diane George, MD, James Garvin, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 4510.
https://doi.org/10.1182/blood.V104.11.4510.4510
Published: 2004
Journal Articles

Reduced Intensity (RI) Allogeneic Stem Cell Transplantation (ALLOSCT) with Umbilical Cord Blood (UCB) in Pediatric Patients with Malignant and Non-Malignant Diseases.

Mary Brigid Bradley, MD, Lauren Harrison, RN, Genia Billote, RN, Erin Cooney, CPNP, Gerard Reddy, Olga Militano, Pharm, Karen Wolownik, CPNP, Ria Hawks, MSN, PNP, Diane George, MD, Gustavo Del Toro, MD, James Garvin, MD, PhD, Monica Bhatia, MD, Prakash Satwani, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 5167.
https://doi.org/10.1182/blood.V104.11.5167.5167
Published: 2004